BiochemistrybioRxiv
Structure-Based Design of a Cyclic Peptide Inhibitor of the SARS-CoV-2 Main Protease
A. G. Kreutzer, M. Krumberger, C. M. T. Parrocha…·J. S. Nowick
This paper designs and evaluates a cyclic peptide inhibitor of SARS-CoV-2 main protease, showing in vitro activity and low toxicity to human cells.
DOI 10.1016/j.ejmech.2021.113530